Lorbas - Market giving 100-200% with much less tha
Post# of 148279
(Total Views: 298)
Posted On: 12/03/2019 3:50:25 PM
Lorbas - Market giving 100-200% with much less than such a important results as those today , after positive results with Maraviroc in colon cancer already.
The warrant holders are the problems imo , in one way they do help company in financing , in another hand they damaging pps.
With approval , FDA is very good , fast approval for deadly cancers , especially with medicine without serious side effects...
They probably will start with few patients and BTD , enrollment should be good now because of approval of IRB , this is an easy enrollment , no restrictions ...
And if good results , approval next year , 1H not excluded ..
I am going out now so have a good evening...
All IMO...
The warrant holders are the problems imo , in one way they do help company in financing , in another hand they damaging pps.
With approval , FDA is very good , fast approval for deadly cancers , especially with medicine without serious side effects...
They probably will start with few patients and BTD , enrollment should be good now because of approval of IRB , this is an easy enrollment , no restrictions ...
And if good results , approval next year , 1H not excluded ..
I am going out now so have a good evening...
All IMO...
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼